SELECTIVE SUPRASENSITIVITY TO CALCITONIN-GENE-RELATED PEPTIDE IN THE HANDS IN RAYNAUD'S PHENOMENON
Authors:
- B. HazlemanBHB. Hazleman
- C. DickersonCDC. Dickerson
- M.J. BrownMBM.J. Brown
- 1 December 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 334 (8676) , 1354-1357
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms.Circulation, 1988
- The actions of calcitonin gene related peptide and vasoactive intestinal peptide as vasodilators in man in vivo and in vitro.British Journal of Clinical Pharmacology, 1987
- Potent Vasodilator Activity of Calcitonin Gene-Related Peptide in Human SkinJournal of Investigative Dermatology, 1986
- Laser Doppler flowmetry: in the assessment of peripheral vascular disorders? A preliminary evaluationClinical Physics and Physiological Measurement, 1986
- The blood supply to fingers during Raynaud's attack: a comparison of laser‐Doppler flowmetry with other techniquesClinical Physiology and Functional Imaging, 1985
- Calcitonin gene-related peptide is a potent vasodilatorNature, 1985
- Laser‐Doppler Flowmetry—a Non‐invasive and Continuous Method for Blood Flow Evaluation in Microvascular StudiesActa Medica Scandinavica, 1984
- ON THE NATURE OF RAYNAUD'S PHENOMENON: THE ROLE OF HISTAMINEThe Lancet, 1983
- INTERMITTENT EPOPROSTENOL (PROSTACYCLIN) INFUSION IN PATIENTS WITH RAYNAUD'S SYNDROMEThe Lancet, 1983
- A double blind placebo controlled crossover study of prostacyclin in manLife Sciences, 1979